Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography

Circulation

Volumn 98, Issue 22, 1998, Pages 2415-2421

  Faber, Lothar ^a   Seggewiss, Hubert ^a,b   Gleichmann, Ulrich ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Ablation; Cardiomyopathy; Contrast media; Echocardiography; Hypertrophy

Indexed keywords

CONTRAST MEDIUM;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART CATHETER; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE RESECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032401669     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.22.2415     Document Type: Article

References (25)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-214.
2. Gietzen F, Leuner C, Gerenkamp T, Kuhn H. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery. Eur Heart J. 1994;15:125. Abstract.
3. Gleichmann U, Seggewiss H, Faber L, Fassbender D, Schmidt HK, Strick S. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie. Dtsch Med Wochenschr. 1996;121:679-685.
4. Knight CJ, Kurbann AS, Seggewiss H, Henlein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 1997;95:2075-2081.
5. Kuhn H, Gietzen F, Leuner C, Gerenkamp T. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J. 1997;18:846-851.
6. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol. 1998;31:252-258.
7. Seggewiss H, Gleichmann U, Faber L. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;337:349-350.
8. Faber L, Seggewiss H, Fassbender D, Bogunovic N, Strick S, Gleichmann U. Catheter treatment in hypertrophic obstructive cardiomyopathy: identification of the perfusion area of septal branches by myocardial contrast echocardiography. Eur Heart J. 1997;18(suppl):368. Abstract.
9. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
10. Wigle DE, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92:1680-1692.
11. Sahn DJ, De Maria AN, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Circulation. 1978;58:1072-1083.
12. Pollick C, Rakowsky H, Wigle ED. Muscular subaortic stenosis: The quantitative relationship between SAM and the pressure gradient. Circulation. 1984;69:43-49.
13. Braunwald E, Lambrew CT, Rockoff S, Ross J, Morrow AG. Idiopathic hypertrophie subaortic stenosis: a description of the disease based on analysis of 64 patients. Circulation. 1964;30(suppl IV):3-213.
14. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Circulation. 1994;90:2731-2742.
15. Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N, Chojnowska L, Guize L, Gras D, Jeanrenaud X, Ryden L, and the PIC Study Group. Pacing in hypertrophic obstructive cardiomyopathy. Eur Heart J. 1997;18:1249-1256.
16. McCully RB, Nishimura RA, Tajik AJ, Schaff HY, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 1996;94:467-471.
17. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technique and hemodynamic results of subaortic ventriculotomy. Ann Surg. 1961;154:181-189.
18. Robbins RC, Stinson EB, Daily PO. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 1996;111:586-596.
19. Nishimura RA, Hayes DL, Ilstrup D, Holmes DR, Tajik AJ. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol. 1996;27:421-430.
20. Brock R. Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis). Guy's Hasp Rep. 1957;106:221-228.
21. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1957;20:1-8.
22. Brugada P, De Swart H, Smeets JLRM, Wellens HJJ. Transcoronary chemical ablation of ventricular tachycardia. Circulation. 1989;79:475-482.
23. Faber L, Seggewiss H, Fassbender D, Strick S, Gleichmann U. Guiding of PTSMA in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography: a case report. J Intervent Cardiol. In press.
24. Hina K, Kusachi S, Iwasaka K, Nogami K, Moritani H, Kita T, Taniguchi G, Tsuji T. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol. 1993;16:403-407.
25. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left the ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997;30:8-18.